Intuitive Surgical (ISRG) Active as Citron Research Reaffirms PT, Issues Note
Tweet Send to a FriendGet Alerts ISRG Hot Sheet
Down)
Trade ISRG Now!
Intuitive Surgical, Inc. (Nasdaq: ISRG) shares are active Thursday afternoon as Citron Research reaffirmed its $300 price target and put out another note.
Today's note covers an editorial written in the Journal of the American Medical Association following a report on Wednesday that Intuitive's da Vinci didn't reduce risk of complication in hysterectomy. For the Citron note, click here.
Shares of Intuitivea are up 0.6 percent.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Today's note covers an editorial written in the Journal of the American Medical Association following a report on Wednesday that Intuitive's da Vinci didn't reduce risk of complication in hysterectomy. For the Citron note, click here.
Shares of Intuitivea are up 0.6 percent.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Intuitive Surgical (ISRG) Jury Reaches Positive Verdict in Robot Case; Shares Rise
- Pandora (P) Trades Strong Into Q1 Results
- Cleantech Solutions (CLNT) Goes Red to Green After Yesterday's 159% Rise
Create E-mail Alert Related Categories
Momentum Movers, Trader TalkRelated Entities
Citron Research
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
